Browsing by Author

Now showing items 1-2 of 2

Characterization and phase I study of CLR457, an orally bioavailable pan-class I PI3-kinase inhibitor

Harding, James J.; Bauer, Todd; Tan, Daniel S. W.; Bedard, Philippe L.; Rodon Ahnert, Jordi; Doi, Toshihiko (Springer, 2019-04-15)
Safety, pharmacokinetics, and antitumor activity of the anti-CEACAM5-DM4 antibody–drug conjugate tusamitamab ravtansine (SAR408701) in patients with advanced solid tumors: first-in-human dose-escalation study

Gazzah, A.; Bedard, Philippe L.; Hierro Carbó, Cinta; Kang, Yoon-Koo; Abdul Razak, A.; Ryu, M.-H.; Tabernero Caturla, Josep (Elsevier, 2022-04)